Skip to main content
Firms Should Revisit OTC Reporting Frameworks – Study
A new report from Tabb Group argues that with regulators becoming increasingly strict on OTC derivative trade reporting it is time for firms to consider a comprehensive review of the trade reporting process. The report, Checking in on OTC Reporting Rules was authored by Tabb’s head of derivatives research Russell Rhoads, who points out that a key component to reducing risk levels in financial markets involves regulators having access to timely and accurate data. “With the new regulations mostly set in stone, now may be the best opportunity for firms to consider a comprehensive review of the OTC trade reporting process,” he says.

Please Log in or Register to view this content.

Access to event programmes and latest news is FREE upon registration to approved market participants. Please note that a manual approval process is in place. Registrations are approved during London and New York office hours. Click here to register

To access our full website with over 11,000 articles, please subscribe by clicking here.

Click to log in

Click to subscribe